This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Perrien, D. S. Articles by Gaddy, D. Search for Related Content PubMed PubMed Citation Articles by Perrien, D. S. Articles by Gaddy, D. Pubmed/NCBI databases Gene GEO Profiles HomoloGene UniGene Compound via MeSH Substance via MeSH Hazardous Substances DB RU-486

Inhibin A Is an Endocrine Stimulator of Bone Mass and Strength

Department of Physiology and Biophysics (D.S.P., N.S.A., K.M.N., L.J.S., D.G.) and Department of Orthopaedic Surgery (D.S.P., P.K.E., A.A.C., M.S.B., F.L.S., R.A.S., W.R.H., L.J.S., D.G.), Center for Orthopaedic Research, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205; and Department of Molecular and Cellular Biology (T.M.P.), Baylor College of Medicine, Houston, Texas 77030

Address all correspondence and requests for reprints to: Dana Gaddy, Ph.D., Department of Physiology and Biophysics, University of Arkansas for Medical Sciences, 4301 West Markham, Slot 505, Little Rock, Arkansas 72205. E-mail: gaddydana{at}uams.edu.

Gonadal function plays a major role in bone homeostasis. It is widely held that the skeletal consequences of hypogonadism are solely due to a loss of sex steroids; however, increases in bone turnover begin during perimenopause before decreases in serum estradiol levels. These data and our demonstration that inhibins acutely regulate bone cell differentiation in vitro led us to test whether inhibin A (InhA) regulates bone mass in vivo. Using a transgenic model of inducible human InhA expression, InhA increased total body bone mineral density, increased bone volume, and improved biomechanical properties at the proximal tibia in intact mice and also prevented the loss of BMD and bone volume and strength associated with gonadectomy at both the spine and proximal tibia. In addition, InhA increased mineral apposition rate, double-labeled surface, and serum osteocalcin levels in vivo and osteoblastogenesis ex vivo without affecting osteoclast number or activity. Together these results demonstrate novel stimulatory effects of InhA on the skeleton in vivo. These studies provide in vivo evidence demonstrating that gonadal factors other than sex steroids play an important role in regulating bone mass and strength and, combined with our previous clinical data, suggest that gonadal InhA may be a component of the normal endocrine repertoire that regulates bone quality in both the axial and appendicular skeleton.

This article has been cited by other articles:

				K. L. Walton, Y. Makanji, M. C. Wilce, K. L. Chan, D. M. Robertson, and C. A. Harrison A Common Biosynthetic Pathway Governs the Dimerization and Secretion of Inhibin and Related Transforming Growth Factor {beta} (TGF{beta}) Ligands J. Biol. Chem., April 3, 2009; 284(14): 9311 - 9320. [Abstract] [Full Text] [PDF]

				R. S. Pearsall, E. Canalis, M. Cornwall-Brady, K. W. Underwood, B. Haigis, J. Ucran, R. Kumar, E. Pobre, A. Grinberg, E. D. Werner, et al. A soluble activin Type IIA receptor induces bone formation and improves skeletal integrity PNAS, May 13, 2008; 105(19): 7082 - 7087. [Abstract] [Full Text] [PDF]

				L. J. Suva, E. Hartman, J. D. Dilley, S. Russell, N. S. Akel, R. A. Skinner, W. R. Hogue, U. Budde, K. I. Varughese, T. Kanaji, et al. Platelet Dysfunction and a High Bone Mass Phenotype in a Murine Model of Platelet-Type von Willebrand Disease Am. J. Pathol., February 1, 2008; 172(2): 430 - 439. [Abstract] [Full Text] [PDF]

				G. R. Williams Hypogonadal Bone Loss: Sex Steroids or Gonadotropins? Endocrinology, June 1, 2007; 148(6): 2610 - 2612. [Full Text] [PDF]